Evaluating Multi-Agent LLM Architectures for Rare Disease Diagnosis
On the map: LLM agents and tool use → Medical and scientific domain agents
Abstract (arXiv)
While large language models are capable diagnostic tools, the impact of multi-agent topology on diagnostic accuracy remains underexplored. This study evaluates four agent topologies, Control (single agent), Hierarchical, Adversarial, and Collaborative, across 302 cases spanning 33 rare disease categories. We introduce a Reasoning Gap metric to quantify the difference between internal knowledge retrieval and final diagnostic accuracy. Results indicate that the Hierarchical topology (50.0% accuracy) marginally outperforms Collaborative (49.8%) and Control (48.5%) configurations. In contrast, the Adversarial model significantly degrades performance (27.3%), exhibiting a massive Reasoning Gap where valid diagnoses were rejected due to artificial doubt. Across all architectures, performance was strongest in Allergic diseases and Toxic Effects categories but poorest in Cardiac Malformation and Respiratory cases. Critically, while the single-agent baseline was generally robust, all multi-agent systems, including the Adversarial model, yielded superior accuracy in Bone and Thoracic disease categories. These findings demonstrate that increasing system complexity does not guarantee better reasoning, supporting a shift toward dynamic topology selection.
Key facts. No citing papers in the map yet (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 3 of its 4 references that are in the map. First posted on arXiv 6 Mar 2026.
Builds on
3 of 4 references.
Closest ancestors · 1
Same direction, newest first
Other references · 2
Built on by
Not cited yet.
Similar, not cited
Close in wording, no citation either way
- 2025MACD: Multi-Agent Clinical Diagnosis with Self-Learned Knowledge for LLM
- 2026Teaching agentic AI to generalize expert diagnostic reasoning in rare diseases
- 2026Do Mixed-Vendor Multi-Agent LLMs Improve Clinical Diagnosis?
- 2026LatentDx: Latent Multi-Agent Communication for Cross-Hospital Rare-Disease Diagnosis
- 2025An Agentic System for Rare Disease Diagnosis with Traceable Reasoning
- 2025Learning to reason about rare diseases through retrieval-augmented agents
- 2026MDIA: A Multi-Agent Diagnostic Intelligence Pipeline on HealthBench Professional
- 2026MedMASLab: A Unified Orchestration Framework for Benchmarking Multimodal Medical Multi-Agent Systems